Incyte Corp (NASDAQ:INCY)

85.63
Delayed Data
As of Jun 26
 -1.98 / -2.26%
Today’s Change
57.00
Today|||52-Week Range
89.30
+34.66%
Year-to-Date

Today’s Trading

Previous close87.61
Today’s open87.54
Day’s range85.22 - 88.28
Volume1,226,218
Average volume (3 months)1,291,333
Market cap$19.0B
Data as of 3:59pm ET, 06/26/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+180.44%
Earnings growth (next 5 years)+35.60%
Revenue growth (last year)+22.50%
P/E ratio73.2
Price/Sales7.29
Price/Book9.82

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.87-1.04%
SGENSeattle Genetics Inc-1.42-2.06%
ARRYArray Biopharma Inc-0.09-0.19%
MYLMylan NV+0.01+0.05%
Data as of 4:00pm ET, 06/26/2019

Financials

Next reporting dateJuly 31, 2019
EPS forecast (this quarter)$0.28
Annual revenue (last year)$1.9B
Annual profit (last year)$109.5M
Net profit margin5.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
Christiana Stamoulis
Corporate headquarters
Wilmington, Delaware

Forecasts